Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PBE vs. FBDIX: which is better?

Bottom line

PBE vs FBDIX: the short answer

PBE (Invesco Biotechnology & Genome ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are both etfs.

But FBDIX is far broader, holding 126 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.

PBE is cheaper at 0.59% vs 1.01% — a difference of $42 a year per $10,000 invested.

Over five years, FBDIX returned +5.0% a year vs +3.4% for PBE.

FBDIX has a front-end sales load of up to 5.5%; the other does not.

Updated Nov 19, 2026

PBE vs FBDIX side by side

PBEFBDIX
TypeETFMutual fund
Fund familyInvescoFranklin Templeton
CategoryTechnology SectorTechnology Sector
Expense ratio0.59%1.01%
Annual cost per $10k$59$101
10-yr cost on $10k (prospectus)$738$1,728
Max front loadNone5.5%
12b-1 fee—0.25%
1-yr return+24.7%+43.9%
5-yr return (annualized)+3.4%+5.0%
10-yr return (annualized)+5.2%+6.4%
Best quarter+25.3%+29.5%
Worst quarter−24.3%−24.5%
Net assets (fund)$281.9M$1.2B
Number of holdings33126
Portfolio turnover103%38%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPBEFBDIXDifference
2025+24.7%+52.3%−27.6%
2024+1.1%+4.0%−2.9%
2023+3.7%+18.4%−14.7%
2022−10.8%−12.7%+1.9%
2021+1.6%−17.7%+19.3%
2020+25.5%+29.9%−4.4%
2019+18.3%+34.8%−16.6%
2018+0.2%−15.7%+16.0%
2017+22.4%+18.8%+3.6%
2016−23.0%−17.2%−5.9%

Source: Fund prospectus bar charts

Holdings overlap

5 of PBE's top 25 holdings also appear in FBDIX's top 25.

Shared top holdings
HoldingPBEFBDIX
Regeneron Pharmaceuticals, Inc.5.47%3.77%
Amgen Inc.5.22%4.39%
Vertex Pharmaceuticals Inc.4.99%3.54%
Gilead Sciences, Inc.4.43%3.86%
Neurocrine Biosciences, Inc.2.66%1.82%

Source: SEC Form N-PORT

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

FBDIX top 10

  1. Jazz Pharmaceuticals plc — 5.66%
  2. Amgen, Inc. — 4.39%
  3. Gilead Sciences, Inc. — 3.86%
  4. Regeneron Pharmaceuticals, Inc. — 3.77%
  5. Argenx SE — 3.62%
  6. Vertex Pharmaceuticals, Inc. — 3.54%
  7. Franklin Institutional U.S. Government Money Market Fund — 3.18%
  8. Revolution Medicines, Inc. — 3.01%
  9. Guardant Health, Inc. — 2.76%
  10. Ascendis Pharma A/S — 2.56%

FAQ

What is the difference between PBE and FBDIX?
PBE (Invesco Biotechnology & Genome ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are both etfs. But FBDIX is far broader, holding 126 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.
Which is cheaper, PBE or FBDIX?
PBE has the lower expense ratio (0.59%).
Should I own both PBE and FBDIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.